Is this you? Create Your Porfile
Avatar

P. Le Jeunne

IMS Health

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where P. Le Jeunne is active.

Explore More

Publication

Featured researches published by P. Le Jeunne.

British Journal of Clinical Pharmacology | 2005

Ineffectiveness of lipid‐lowering therapy in primary care

E. Van Ganse; T. Souchet; L. Laforest; P. Moulin; M Bertrand; P. Le Jeunne; Noémie Travier; D. Yin; Evo Alemao; G. de Pouvourville

Atherosclerosis | 2006

Long-term achievement of the therapeutic objectives of lipid-lowering agents in primary prevention patients and cardiovascular outcomes: an observational study.

E. Van Ganse; T. Souchet; L. Laforest; P. Moulin; M Bertrand; P. Le Jeunne; Stephanie Chretin; D. Yin; Evo Alemao; G. de Pouvourville

Annales De Dermatologie Et De Venereologie | 2016

Maintien au long cours des biothérapies dans le traitement du psoriasis : premières données françaises en vie réelle ☆

D. Jullien; C. Bellagarde; C. Contré; N El Mouaddin; P. Le Jeunne; C. Paul

Value in Health | 2017

Long-Term Impact of Grass-Pollen (GP) Sublingual Immunotherapy Tablet (SLIT) on Allergic Rhinitis (AR) and on Allergic Asthma (AA) Onset and Progression

P Devillier; M Molimard; P Demoly; X. Ansolabehere; I Bardoulat; N Coulombel; F Maurel; P. Le Jeunne

Value in Health | 2016

Real Life Progression Free Survival and Treatment Patterns For Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapies in France: Analysis of Ims Rwd Oncology Cross-Sectional Survey Data

Rana Maroun; L Mitrofan; Laure Benjamin; Gaëlle Nachbaur; Franck Maunoury; P. Le Jeunne; Durand-Zaleski

Value in Health | 2014

Persistence to Treatment of Chronic Hepatitis B Virus (Hbv) Infection: A Study Based on the French Ims Lifelink Treatment Dynamics (LTD) Database.

N El Mouaddin; N. Grandfils; P. Le Jeunne; B. Beaupere; S. Pol

Diabetes & Metabolism | 2014

PO9 Diabète de type 2 : quels objectifs thérapeutiques selon les nouvelles recommandations de l’HAS ? Analyse de 6 680 patients suivis par des médecins généralistes

E. Larger; X. Ansolabehere; N. Grandfils; P. Le Jeunne

Value in Health | 2013

Consistency of Current Type 2 Diabetes (T2DM) Treatment Patterns in General Practice Versus the 2013 French Has T2DM Guidelines: A Transversal Study Based on the French IMS LifelinkTM Prospective Diabetes Cohort

E. Larger; X. Ansolabehere; P. Le Jeunne; N. Grandfils; Y. Briand; B. Gibelin

Value in Health | 2013

Do Fixed-Dose Combinations Improve Antidiabetic Treatment Compliance? A Study Based on French IMS Lifelink Disease Analyzer Database

N. Grandfils; P. Le Jeunne; C. Maillard; A. Solomiac; A. Besson

Value in Health | 2013

Screening Characteristics and Diabetes Biomarkers in French and UK Patient-Level Databases

C. Cabrera; P. Le Jeunne; A. Lee; F. Thomas; N. Mian; A. McDonell

Explore More

Collaboration

Dive into the P. Le Jeunne's collaboration.

Top Co-Authors
Avatar

N. Grandfils

IMS Health

View shared research outputs
Top Co-Authors
Avatar

X. Ansolabehere

IMS Health

View shared research outputs
Top Co-Authors
Avatar

D. Yin

Merck

View shared research outputs
Top Co-Authors
Avatar

Evo Alemao

Merck

View shared research outputs
Top Co-Authors
Avatar

T. Souchet

Merck

View shared research outputs
Top Co-Authors
Avatar

L. Laforest

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors
Avatar

N El Mouaddin

IMS Health

View shared research outputs
Top Co-Authors
Avatar

Stephanie Chretin

University of Lyon

View shared research outputs
Top Co-Authors
Avatar

C. Bellagarde

Janssen Pharmaceutica

View shared research outputs
Top Co-Authors
Avatar

C. Contré

Janssen Pharmaceutica

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge